breast tumor
Conditions
Interventions
Case series:intercostal nerve block in anterior approach with 0.375% ropivacaine
Sponsors
Department of Anesthesiology, Fudan University Shanghai Cancer Centre, Department of Oncology, Shanghai Medical College Fudan University Shanghai
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women scheduled for breast lumpectomy under ICB and classified as ASA (American Society of Anesthesiologists Physical Status) physical status I-III were eligible for the study.
Exclusion criteria
Exclusion criteria: 1. Patients with bilateral ICB; 2. Patients with a history of local anesthetic allergy; 3. Patients with infection of puncture site; 4. Patients with idiopathic facial paralysis and other neuropathy; 5. Patients with stroke and transient ischemic attack; 6. Patients with coagulation dysfunction; 7. Patients undergoing anticoagulation surgery; 8. Glaucoma, cataract and other eye diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Horner’s syndrome;body mass index;age;the dose of ropivacaine; | — |
Secondary
| Measure | Time frame |
|---|---|
| other adverse events;Duration of ICB;Intercostal space of ICB;The location of the mass (Left breast or right breast);Duration of the surgery (min); | — |
Countries
China
Contacts
Public ContactSun Zhirong
Cancer Hospital of Fudan University/ Cancer Research Institute, Shanghai Medical College of Fudan University
Outcome results
None listed